By performing a large-scale biobank-based genome-wide association study, we identified a strong link between the underlying risk of cardiometabolic disease and patterns of lifelong medication use in hyperlipidemia, hypertension and type 2 diabetes. We discover hundreds of genetic predictors of medication use behavior and show medication-use-enhanced applications for polygenic prediction in cardiometabolic diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018). A review article that presents global burden of 354 disease including cardiovascular diseases.
Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl. J. Med. 330, 1041–1046 (1994). This paper reports heritability estimates for coronary heart disease.
SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy—a genomewide study. New Engl. J. Med. 359, 789–799 (2008). A review article that presents evidence for adverse reactions to statin use for individuals carrying risk variants in the SLCO1B1 gene.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Kiiskinen, T. et al. Genetic predictors of lifelong medication use patterns in cardiometabolic diseases. Nat. Med. https://doi.org/10.1038/s41591-022-02122-5 (2023).
Rights and permissions
About this article
Cite this article
Genetic prediction of medication use patterns in cardiometabolic disease. Nat Med 29, 43–44 (2023). https://doi.org/10.1038/s41591-022-02124-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02124-3
